ReadYourDNA

Amphetamine (Adderall)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Amphetamine

What it is

Amphetamine is a central nervous system stimulant: it makes nerve cells release more dopamine and noradrenaline and blocks their reuptake. It is used for ADHD (attention deficit hyperactivity disorder) and for narcolepsy. It is sold as Adderall (a mix of amphetamine salts), Evekeo and other names, and is closely related to lisdexamfetamine and dexamfetamine.

How genes come into it

Amphetamine is cleared partly unchanged in the urine and partly by the liver enzyme CYP2D6. The US FDA lists CYP2D6 poor metabolizers for amphetamine products, since their exposure can be higher; there is no CPIC or DPWG guideline. A few studies have looked at dopamine-related genes such as DRD2 and SLC6A3 and at OPRM1, with weak evidence.

Published guidelines

Clinical guidelines that name a gene for Amphetamine. They sort people into groups by the gene copies they carry.

US FDA: CYP2D6. CYP2D6 activity score 0. Data that Support Therapeutic Management Recommendations.

What research found

Every published finding on gene variants and Amphetamine. Upload your DNA file to see which of these rows apply to you.

Rated evidence (4 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

OPRM1 rs2281617: Level 3. Other. 1.

OPRM1 rs510769: Level 3. Efficacy. 1.

KAT2B rs9829896: Level 3. Toxicity: Substance-Related Disorders. 1.

DRD2 rs12364283: Level 3. Other. 1.

Metabolism (1 finding)

Studies of how quickly the body processes this medication.

CYP2D6 CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36: CYP2D6 *4/*10 + *5/*10 + *5/*14 + *10/*10 + *10/*18 + *10/*36 (assigned as intermediate metabolizer phenotype) are not associated with concentrations of amphetamine as compared to CYP2D6 *1/*1 + *1/*2 + *1/*5 + *1/*10 + *2/*2 + *2/*4 + *2/*5 + *2/*10 (assigned as normal metabolizer phenotype) .

Response (2 findings)

Studies of how well it worked in people carrying a variant.

CDH13 rs3784943: Genotypes AG + GG is associated with increased response to amphetamine as compared to genotype AA.

CYP2D6 CYP2D6 poor metabolizer: CYP2D6 poor metabolizer is associated with increased clinical benefit to amphetamine or lisdexamfetamine in children with Attention Deficit Disorder with Hyperactivity as compared to CYP2D6 normal metabolizer.

Dosing (1 finding)

Studies of how much of the drug people needed or tolerated.

SLC6A3 rs460000: Genotype GG is associated with increased response to amphetamine in healthy individuals as compared to genotypes GT + TT.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Cocaine (Stimulants)

Dexedrine (Stimulants)

Ritalin (Stimulants)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com